Education
About Us
Working with TipRanks
Follow Us
Clover Health Investments Corp (DE:7QD)
:7QD
RESEARCH TOOLSreports
7QD Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.94 - €4.55
Previous CloseN/A
Volume0.00
Average Volume (3M)4.00
Market Cap
€1.32B
Enterprise Value€344.74M
Total Cash (Recent Filing)€160.09M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.07
Next Earnings
Aug 11, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding416,541,560
10 Day Avg. Volume0
30 Day Avg. Volume4
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.27
Price to Sales (P/S)0.00
P/FCF Ratio-2.12
Enterprise Value/Market Cap0.26
Enterprise Value/Revenue0.06
Enterprise Value/Gross Profit0.88
Enterprise Value/Ebitda-1.24
Forecast
1Y Price Target
€4.12Price Target Upside59.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Clover Health Investments News
PremiumCompany Announcements
Clover Health Prepares for Q1 2025 Earnings Release
PremiumCompany Announcements
Clover Health’s Earnings Call Highlights Growth and Optimism
PremiumCompany Announcements
Clover Health Sees Strong Growth in Q1 2025
Bulls Say, Bears Say
Bulls Say
EarningsCLOV reported adjusted EBITDA of $25.8m, exceeding expectations and consensus, and raised the low end of the EBITDA guidance.
Financial PerformanceClover finished 2024 with significant momentum, delivering its first full year of positive adj-EBITDA, posting $70.1 million.
GrowthClover outperformed for the 2025 AEP period, growing membership by 27%.
Bears Say
Cash FlowClover's cash from operations was ($16.3) million in 1Q with cash and cash equivalents declining to $390.8 million.
ExpensesBER is expected to be 87-88% in 2025 vs. 81.2% in 2024, indicating increased expenses.
RevenueReported revenues of $462m missed consensus and estimate by 1.0% and 3.1%, respectively.
Options Prices
Currently, No data available
---
Ownership Overview
8.18% Insiders
5.93%
Mutual Funds
1.89% Other Institutional Investors
76.94% Public Companies and Individual Investors
7QD FAQ
What was Clover Health Investments Corp’s price range in the past 12 months?
Clover Health Investments Corp lowest stock price was €0.94 and its highest was €4.55 in the past 12 months.
What is Clover Health Investments Corp’s market cap?
Clover Health Investments Corp’s market cap is €1.32B.
When is Clover Health Investments Corp’s upcoming earnings report date?
Clover Health Investments Corp’s upcoming earnings report date is Aug 11, 2025 which is in 60 days.
How were Clover Health Investments Corp’s earnings last quarter?
Clover Health Investments Corp released its earnings results on May 06, 2025. The company reported €0.047 earnings per share for the quarter, beating the consensus estimate of -€0.037 by €0.084.
Is Clover Health Investments Corp overvalued?
According to Wall Street analysts Clover Health Investments Corp’s price is currently Undervalued.
Does Clover Health Investments Corp pay dividends?
Clover Health Investments Corp does not currently pay dividends.
What is Clover Health Investments Corp’s EPS estimate?
Clover Health Investments Corp’s EPS estimate is >-0.01.
How many shares outstanding does Clover Health Investments Corp have?
Clover Health Investments Corp has 416,541,560 shares outstanding.
What happened to Clover Health Investments Corp’s price movement after its last earnings report?
Clover Health Investments Corp reported an EPS of €0.047 in its last earnings report, beating expectations of -€0.037. Following the earnings report the stock price went up 1.923%.
Which hedge fund is a major shareholder of Clover Health Investments Corp?
Currently, no hedge funds are holding shares in DE:7QD
Clover Health Investments Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€4.12 (59.84% Upside)
€4.12 (59.84% Upside)
Blogger Sentiment
Bullish
DE:7QD Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $722.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
188.34%
12-Months-Change
Fundamentals
Return on Equity
-7.75%
Trailing 12-Months
Asset Growth
-13.11%
Trailing 12-Months
Company Description
Clover Health Investments Corp
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
7QD Company Deck
7QD Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call depicted a largely positive outlook for Clover Health, marked by significant growth in membership, revenue, and adjusted EBITDA. The company effectively highlighted its successful initiatives and technological advancements with Clover Assistant. Financial metrics showed considerable improvement, and the positive CMS rate notice added to the optimistic future outlook. However, there were some challenges with elevated inpatient utilization and past operational issues with claims payable, but these were minor in comparison to the overall robust performance.Read More>7QD Stock 12 Month Forecast
Average Price Target
€4.12
▲(59.84%Upside)